| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABIOMED INC | 3,150,000 | 225,477,000 | 44.73% | ||
| 2 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 95,193,000 | 18.88% | ||
| 3 | ENTELLUS MEDICAL INC | 3,813,196 | 83,509,000 | 16.57% | ||
| 4 | CORIUM INTERNATIONAL INC | 9,353,304 | 61,264,000 | 12.15% | ||
| 5 | ENDOLOGIX INC | 1,257,468 | 26,843,000 | 5.32% | ||
| 6 | ACURA PHARMACEUTICALS INC | 10,284,886 | 7,727,000 | 1.53% | ||
| 7 | MEDICINOVA INC COM NEW | 1,170,370 | 4,096,000 | 0.81% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001001, filed 2015.05.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
